Paper1751544
The trk family of tyrosine protein kinase receptors.
Barbacid M and 3 others. Biochim Biophys Acta, 1991. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. The trk family of tyrosine protein kinase receptors. Papers, record 1751544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1751544
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multigene Family | Major topic |
| Oncogenes | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Proto-Oncogenes | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Drosophila | |
| Humans | |
| Molecular Sequence Data | |
| Neoplasms | |
| Receptor, trkA |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37958963 | Analysis of CD74 Occurrence in Oncogenic Fusion Proteins. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958963 | PubMed |
| 37869783 | Safety of current treatment options for NTRK fusion-positive cancers. | Expert Opin Drug Saf | 2023 | https://conductscience.org/library/papers/37869783 | PubMed |
| 37812694 | Phase separation underlies signaling activation of oncogenic NTRK fusions. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37812694 | PubMed |
| 36362354 | Unleashing Intrinsic Growth Pathways in Regenerating Peripheral Neurons. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36362354 | PubMed |
| 35907096 | Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases. | EJNMMI Res | 2022 | https://conductscience.org/library/papers/35907096 | PubMed |
| 34531526 | NTRK insights: best practices for pathologists. | Mod Pathol | 2022 | https://conductscience.org/library/papers/34531526 | PubMed |
| 34176200 | Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion. | Oncologist | 2021 | https://conductscience.org/library/papers/34176200 | PubMed |
| 32394943 | The role of the TrkB-T1 receptor in the neurotrophin-4/5 antagonism of brain-derived neurotrophic factor on corticostriatal synaptic transmission. | Neural Regen Res | 2020 | https://conductscience.org/library/papers/32394943 | PubMed |
| 32093103 | Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32093103 | PubMed |
| 31965543 | The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers. | Paediatr Drugs | 2020 | https://conductscience.org/library/papers/31965543 | PubMed |
| 31738427 | Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. | Ann Oncol | 2019 | https://conductscience.org/library/papers/31738427 | PubMed |
| 31602824 | Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma. | J Korean Med Sci | 2019 | https://conductscience.org/library/papers/31602824 | PubMed |
| 30608586 | Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications. | Hum Reprod Update | 2019 | https://conductscience.org/library/papers/30608586 | PubMed |
| 30333516 | NTRK fusion-positive cancers and TRK inhibitor therapy. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/30333516 | PubMed |
| 26125608 | AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy. | Gene Ther | 2016 | https://conductscience.org/library/papers/26125608 | PubMed |
| 24860421 | Regulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player. | Front Mol Neurosci | 2014 | https://conductscience.org/library/papers/24860421 | PubMed |
| 24023598 | Tropomyosin-receptor-kinases signaling in the nervous system. | Maedica (Bucur) | 2013 | https://conductscience.org/library/papers/24023598 | PubMed |
| 23749991 | Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23749991 | PubMed |
| 22474604 | NGF, brain and behavioral plasticity. | Neural Plast | 2012 | https://conductscience.org/library/papers/22474604 | PubMed |
| 20300619 | Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. | PLoS One | 2010 | https://conductscience.org/library/papers/20300619 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NTRK1 | 4914 | PubTator's text mining | https://conductscience.org/library/genes/4914 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1751544
GET https://conductscience.org/api/papers/v1/1751544/cited_by?page=2